Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01275820 · ClinicalTrials.gov registry record

A Study to Evaluate Glucose and Insulin Response to Nutralin

A clinical trial of Diabetes, sponsored by Avera McKennan Hospital & University Health Center.

Completed
Registry status
10
Enrollment target
1
Study location

NCT01275820 is a study of Diabetes that has completed, run by Avera McKennan Hospital & University Health Center. The registered enrollment target is 10 participants, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01275820, a study of Diabetes, has completed, sponsored by Avera McKennan Hospital & University Health Center.

COMPLETED
Registry status
10 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate how an investigational food product affects a healthy person's blood sugar and insulin levels.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Nutralin

Study Locations (1)

South Dakota

  • Avera Research Institute - Sioux Falls

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2010-06
Est. Completion 2010-09

What the Registry Record Tells You About NCT01275820

The ClinicalTrials.gov registry entry for NCT01275820 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (100% lower). The listed sponsor is Avera McKennan Hospital & University Health Center, which has 20 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Nutralin is the first listed.

NCT01275820 reports 1 study location spanning 1 distinct geographic area - top geographies include South Dakota.

Frequently Asked Questions

What is clinical trial NCT01275820 about?

NCT01275820 is a clinical study titled "A Study to Evaluate Glucose and Insulin Response to Nutralin". The purpose of this study is to evaluate how an investigational food product affects a healthy person's blood sugar and insulin levels.

What is the current status of trial NCT01275820?

This trial is currently completed. The enrollment target is 10 participants. The study started on 2010-06. Estimated completion is 2010-09.

What conditions does trial NCT01275820 study?

This clinical trial studies the following conditions: Diabetes.

What interventions are being tested in trial NCT01275820?

The interventions under investigation include: Nutralin (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT01275820?

This trial is sponsored by Avera McKennan Hospital & University Health Center, which has 20 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01275820 being conducted?

This trial has 1 study location across South Dakota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.